SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (111)11/3/2003 6:48:13 PM
From: Miljenko Zuanic  Read Replies (1) of 411
 
Most likely.

Also, imo, the main question is not “will or will not CVTX run new trial”, it is what trial they will need to run and what are R chances for success? AC is to give FDA/CVTX guidance for this trial(s).

Approval time-frame is moved forward by at least 24 months, imo. I am expecting further decline in CVTX stock price (after AC). Good that they are moving forward with other candidates.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News